Immunohelix Alternatives & Competitors

12 companies similar to Immunohelix

Genenta Science (Nasdaq: GNTA)

Genenta is a clinical stage immuno-oncology company

25 Post-IPO Secondary $32.60M

Milan, Italy

Biotechnology Health Care

Cornerstone Pharmaceuticals

Rare Science. Rare Compassion. Rare Solutions.

Cranbury, United States

Biotechnology Pharmaceutical

Priothera SAS

Adding Quality Years of Life

21 Debt Financing $49.00M

France

Biotechnology Health Care +1

Appia Bio

Collaborates across a diversity of disciplines, which is critical to developing next-gener...

13 Series A $52.00M

Biotechnology Health Care +2

Track all Immunohelix competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

ACM Biolabs

19 Venture round $6.80M

Singapore, Singapore

Biotechnology Health Care

AFFIRMA BIOTECH SL

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant an...

5 Venture round $1.98M

Barcelona, Spain

Biopharma Biotechnology +2

PuREC Co.Ltd.

Ultra-pure human bone marrow derived mesenchymal stem cell “REC”

4 Series A $670.00M

Japan

Health Care Health and Wellness +1

ImmunoCellular Therapeutics Ltd

Pioneering immune-based therapies to harness the body's defenses against cancer through ad...

11 Grant $32.47M

Calabasas, United States

Biotechnology Health Care

Venatorx Pharmaceuticals, Inc.

Discovering & developing novel anti-infectives to treat multi-drug resistant bacterial & h...

33 $159.92M

Malvern, United States

Health Care Pharmaceutical

Rodos Biotarget GmbH

Your partner with longstanding expertise in nanomedicine development and nanoparticle form...

2-10 Equity Crowdfunding $2.77M

Biopharma Biotechnology +1

Altheia Science

Altheia Science develops treatments for autoimmune diseases and cancer using innovative to...

6 Series A $11.00M

Milano, Italy

Biotechnology Health Care +1

River BioMedics

River BioMedics paves the way to the future of cardiac drug discovery

13 Seed $1.80M

Enschede, The Netherlands

Biotechnology Health Care +1

About Immunohelix

Immunohelix is a biotechnology startup founded in 2022 that focuses on immuno-modulation through cell-specific delivery of oligonucleotide drugs to antigen-presenting cells. The company is currently working on groundbreaking anti-GVHD drug for hematopoietic stem cell transplantation in hematological cancers and has com...

Business keywords

Immunomodulation, Oligonucleotide Drugs, Antigen Presenting Cells, Anti-GVHD Drug, Hematopoietic Stem Cell Transplantation, Hematological Cancers, Pharmaceutical Company

Frequently Asked Questions

Companies similar to Immunohelix include Genenta Science (Nasdaq: GNTA), Cornerstone Pharmaceuticals, Priothera SAS, Appia Bio, ACM Biolabs. They work in Biotechnology and Health Care and share Immunohelix's focus on immunomodulation and pharmaceutical company.

Bounce Watch lists 12 companies that share Immunohelix's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Immunohelix and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Immunohelix Profile Genenta Science (Nasdaq: GNTA) Alternatives Cornerstone Pharmaceuticals Alternatives Priothera SAS Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Immunohelix on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.